Supplied under strict cGMP protocols with complete analytical dossiers. Every batch features quantitative marker assays, physical particle characterisation, and contaminant screening tailored to Australian complementary medicine requirements.
Procuring bulk herbal extract powders in Australia demands a comprehensive understanding of regulatory frameworks far more stringent than standard dietary supplement classifications. We ensure complete alignment with PIC/S GMP principles, TGA monographs, and DAFF import conditions.
Under the Australian Therapeutic Goods Act 1989 and relevant Therapeutic Goods Orders (including TGO 92 and TGO 100), raw herbal powders destined for Listed Medicines (AUST L) must undergo validated identification and assay validation prior to compounding. Our technical release file ensures sponsors fulfill their pre-market compliance responsibilities without qualification bottlenecks.
| Target Parameter | Standard Methodology | Australian & International Threshold | Regulatory Significance |
|---|---|---|---|
| Species Identity & Fingerprinting | HPTLC / DNA Barcoding | Conforms to reference monograph profile (BP/Ph. Eur./USP) | Excludes adulterants (e.g., adulteration of Stephania, Aristolochia, or Ginkgo) |
| Quantitative Active Marker | Validated HPLC-DAD / LC-MS | Strict percentage tolerance against Certificate of Analysis specification | Supports therapeutic dose substantiation under TGA permitted indications |
| Heavy Metal Speciation | ICP-MS (Inductively Coupled Plasma) | Pb < 3.0 ppm, As < 1.0 ppm, Cd < 0.5 ppm, Hg < 0.1 ppm | Guarantees safety margins within permitted daily exposure (PDE) limits |
| Residual Solvent Screening | Headspace GC-MS | ICH Guideline Q3C (Class 1 absent; Class 2 & 3 within limits) | Zero benzene, carbon tetrachloride; strict ethanol/water residual control |
| Microbiological Bioburden | Plate Count / Membrane Filtration | TAMC ≤ 10^3 CFU/g, TYMC ≤ 10^2 CFU/g, E. Coli & Salmonella absent | Mandatory for non-sterile oral therapeutic dosage forms (TGO 100) |
| DAFF Biosecurity Clearance | BICON Plant Material Criteria | Dry heat / gamma irradiation declared; zero soil, seeds, or foreign pathogens | Facilitates unconditional release through Department of Agriculture inspection |
Different delivery matrices demand specific rheological and physical properties. From high-speed rotary tableting machines in Melbourne to RTD beverage pasteurisation in Sydney, our bulk herb powders are tailored to exact manufacturing parameters.
Engineered exclusively for TGA-registered contract manufacturers (CMOs). High-tapped bulk density, low hygroscopicity, and validated particle size distribution (80–120 mesh) prevent capping and laminating in high-speed rotary tablet presses and automated capsule filling machines.
Australia’s ready-to-drink wellness beverage sector requires micro-filtered, agglomerated botanical powders that disperse rapidly in cold or ambient liquids without sediment precipitation, haze formation, or bitter off-notes that overpower organic flavour profiles.
Pre-workout powders, intra-workout electrolytes, and adaptogenic recovery formulas demand high-potency standardized phytochemicals (e.g., eurycomanone, ginsenosides) that remain stable when dry-blended with BCAAs, minerals, and natural sweetening systems.
Pectin- and gelatin-based functional confectionery requires heat-tolerant botanical extracts that withstand continuous cook temperatures of 105°C–115°C without active marker degradation, acid inversion, or structural setting destabilisation.
Clean-label Australian skincare brands formulate with solvent-free, highly purified antioxidant extracts (polyphenols, elderberry anthocyanins). These powders readily solubilize into lipid or aqueous phases, yielding stable serums, creams, and cosmetic emulsions.
Australian equine and canine vitality formulations incorporate high-density bulk adaptogens, nettle root, and immune-supportive polysaccharides. All lots feature complete elemental and microbiological documentation meeting APVMA manufacturing standards.
The Australian wellness and complementary medicine market is undergoing rapid evolution. Formulators are transitioning from general crude powders to clinically supported, high-transparency standardized extracts.
Australian regulatory bodies and sophisticated brand QA teams increasingly reject undocumented "10:1" or "20:1" claims. The procurement standard has pivoted irreversibly toward verified active marker percentages (e.g., Withanolides, Eurycomanone, Ginsenosides) measured by validated HPLC chromatography.
Consumer resistance to maltodextrin, silicon dioxide, and synthetic flow agents has driven high demand for 100% pure botanical powders, native plant fibers, or organic acacia gum as gentle carrier substitutes, necessitating advanced spray-drying engineering at the source.
Australia has experienced unprecedented growth in cognitive formulations. Formulators require authentic fruiting body extracts of Lion's Mane, Reishi, and Cordyceps with quantified β-glucan assays, completely free of residual grain substrate starch or adulterated myceliated biomass.
The global focus on metabolic health, glucose management, and AMPK activation has established Berberine HCl and standardized Polyphenolic powders as cornerstone ingredients across premium pharmacy and direct-to-consumer healthcare brands nationwide.
Following post-pandemic shipping disruptions, Australian procurement managers prioritise suppliers who offer pre-cleared DAFF biosecurity import permits, correct BICON documentation, and irradiation-free sterilization pathways (such as high-pressure steam treatment).
Contract manufacturers in New South Wales, Victoria, and Queensland are mitigating sea-freight volatility by establishing standing rolling purchase orders and dedicated buffer stocks of key adaptogens, avoiding multi-week downtime during peak compounding cycles.
Built upon pharmaceutical-grade quality frameworks, rigorous batch-to-batch reproducibility, and transparent technical documentation designed to simplify supplier qualification for Australian QA teams.
Produced in state-of-the-art facilities audited against PIC/S and ISO 22000 quality systems, ensuring complete data integrity, batch tracking, and full sanitation protocols.
Each delivery includes a batch CoA, full manufacturing process flowchart, Safety Data Sheet (SDS), Allergen Matrix, Non-GMO declaration, and Residual Solvent certificate.
Custom physical modification available: particle size tuning from 60 to 200 mesh, micro-encapsulation for moisture-sensitive botanicals, and customized instant water-dispersible milling.
Direct air-courier and full-container ocean freight channels servicing Sydney, Melbourne, Brisbane, and Fremantle with complete customs and DAFF biosecurity clearance assistance.
Essential answers covering technical documentation, TGA compliance, Australian customs and biosecurity clearance, and custom production runs.
Yes. Our standard herbal extract powders are manufactured under PIC/S-aligned GMP facilities. We verify every ingredient against the TGA Permissible Ingredients Determination, ensuring that Latin binominals, plant parts, extraction solvents, and active marker ranges conform precisely to Australian regulatory guidelines.
Importing botanical powders into Australia requires strict adherence to the Department of Agriculture, Fisheries and Forestry (DAFF) biosecurity import conditions (BICON). We provide comprehensive phytosanitary certificates, non-seed declarations, manufacturing process declarations (verifying heating or fine-milling steps), and ensure zero contamination by biological matter.
Every shipment arrives with a full technical release pack: a batch-specific Certificate of Analysis (CoA) with HPLC/UV chromatograms, Safety Data Sheet (SDS), Manufacturing Flowchart, BSE/TSE Free Statement, Non-GMO Certification, Allergen Declaration, and Residual Solvent testing data conforming to ICH limits.
Absolutely. We customize granulation based on your manufacturing needs: 80 to 100 mesh for automated capsule filling, granular 40 to 60 mesh for direct-compression tableting to ensure smooth die flow, and micronized 200+ mesh for transparent dispersion in liquid beverages.
Our standard commercial MOQ is 25 kg (one standard fiber drum with dual food-grade polyethylene liners). For customized pilot batches, laboratory R&D trials, or formulation pilots, we support trial evaluation aliquots from 1 kg to 5 kg upon request.
Yes. Australian clean-label standards prohibit undocumented ionizing radiation and ethylene oxide (ETO) sterilisation. We utilise advanced closed-circuit heat pasteurisation, high-pressure steam, or supercritical extraction to guarantee low bioburden counts without molecular degradation.
Standard air-freight orders arrive at major Australian cargo hubs (SYD, MEL, BNE, PER) within 5 to 8 business days post-dispatch. Sea-freight FCL/LCL shipments typically have a transit window of 18 to 26 days depending on the origin port and customs quarantine intervals.
Our multi-tier identity testing program employs High-Performance Thin-Layer Chromatography (HPTLC) fingerprinting against verified botanical reference standards, alongside microscopic evaluation and genomic testing where required. This completely eliminates species substitution risks.
Connect directly with our technical procurement specialists. Whether you require a pilot trial sample, a custom extract ratio assay, or a comprehensive regulatory dossier for TGA registration, our technical team delivers responsive support within one business day.
Submit your active marker targets, mesh requirements, and estimated volume for an expedited quotation.
Send an Inquiry